SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-024664
Filing Date
2020-05-12
Accepted
2020-05-12 16:14:31
Documents
80
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q beam-10q_20200331.htm 10-Q 2365169
2 EX-31.1 beam-ex311_18.htm EX-31.1 17835
3 EX-31.2 beam-ex312_19.htm EX-31.2 18219
4 EX-32.1 beam-ex321_21.htm EX-32.1 8524
5 EX-32.2 beam-ex322_20.htm EX-32.2 7938
6 GRAPHIC g3d5w4uy4nmd000001.jpg GRAPHIC 44989
  Complete submission text file 0001564590-20-024664.txt   8017323

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT beam-20200331.xml EX-101.INS 1687064
8 XBRL TAXONOMY EXTENSION SCHEMA beam-20200331.xsd EX-101.SCH 61038
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE beam-20200331_cal.xml EX-101.CAL 56512
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE beam-20200331_def.xml EX-101.DEF 199839
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE beam-20200331_lab.xml EX-101.LAB 439864
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE beam-20200331_pre.xml EX-101.PRE 358212
Mailing Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE STREET CAMBRIDGE MA 02139 857-327-8775
Beam Therapeutics Inc. (Filer) CIK: 0001745999 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39208 | Film No.: 20869266
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences